The online home of Neurology Reviews

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Benzodiazepines, Hypnotics Don’t Increase Alzheimer’s Pathology

Publish date:: October 15, 2019

Key clinical point: Benzodiazepines and hypnotics influenced neuronal loss in elderly brains.

Major finding: The drugs were not associated with Alzheimer’s pathology.

Study details: A postmortem substudy of 337 brains from patients in the U.K. Medical Research Council’s Cognitive Function and Ageing Study.

Disclosures: The presenting author reported no financial disclosures.

Citation:

Fox C et al. AAIC 2019, Abstract 34017.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Alzheimer's & Cognition

Mortality burden of dementia may be greater than estimated,

Cognitive deficits complex in youths with type 2 diabetes,

Population study supports migraine-dementia link,

Mixed results for aducanumab in two phase 3 trials for Alzheimer’s disease,

Blood pressure lowering lessens risk of dementia, cognitive decline,

All Specialties